EPIC™ MAX
AORTIC STENTED TISSUE VALVE CLINICAL DATA
The Abbott Epic valve platform has a decades-long history of safety and strong clinical outcomes. Epic Max has an optimized design to further improve valve blood flow.
BUILT ON THE EPIC™ PLATFORM THAT HAS STOOD THE TEST OF TIME
AT 10-YEARS
Over 11,000 Patients
94.6%
Freedom From All-Cause
Reintervention2
Over 1,900 Patients
96.3%
Freedom from SVD
(Structural Valve Degeneration)
All patient age3
COMMITMENT TO VALVE-IN-VALVE* FOLLOW-UP DATA
3-YEAR OUTCOMES OF VALVE-IN-VALVE INTERVENTION
>95.0%
Epic™ Supra Valve
Patients Experienced Freedom from Valve
Intervention4
OPTIMIZE OUTCOMES WITH EXCELLENT HEMODYNAMICS
ESTIMATED EPIC™ MAX MEAN PRESSURE GRADIENTS AT 1 YEAR (MMHG)1
MEAN PRESSURE GRADIENT PREDICTED BASED ON MATCHED STENT ID FOR BIOCOR/EPIC™ VALVES.

Maximizing the internal orifice provides large effective orifice areas (EOAs) and low gradients to reduce the burden on the heart and contribute to better patient outcomes.
The safety and effectiveness of valve-in-valve procedures in an Epic™ Max valve has not been established
DOWNLOAD THE EPIC
MAX CORE BROCHURE
MAT-2307973 v1.0 | Item approved for U.S. use only.